About this trial
Randomised, single-blind clinical trial comparing chlorhexidine gluconate-impregnated transparent dressings versus conventional transparent dressings in the prevention of central venous catheter-related bloodstream infections (CVC-BSI) in paediatric patients admitted to a tertiary hospital PICU. Outcomes include incidence of BRCVC, catheter colonisation, dressing-related skin complications, and number of dressing changes.
Eligibility criteria
Qualifiers
Admission to paediatric intensive care unit (PICU)
Central venous catheter placement (central or peripherally inserted)
Informed consent obtained from parent/legal guardian
Disqualifiers
Known immunological disorders
Neutropenia (<500/mm³)
Pre-existing colonisation or infection with multidrug-resistant organisms
Trial design
Treatments tested in this trial
- 3M™ Tegaderm™ Antimicrobial Transparent Dressing (chlorhexidine gluconate-impregnated)
- Conventional transparent polyurethane dressing
Treatment groups
Sponsors and collaborators
University of Seville
Lead sponsor
Hospitales Universitarios Virgen del Rocío
Collaborator